ADVISORY/Spotfire to Present at Vision in Business 2001 Conference: Reducing In-Vivo Testing and Improving Predictability; Advances in In-Vitro Pre-Clinical Screening.

Business/Technology Editors

ADVISORY...for Wednesday (March 14)

--(BUSINESS WIRE)

Spotfire, Inc.

Who:   Spotfire, Inc., the leading provider of eAnalytic applications

What:  Mark Demesmaeker, Ph.D, Scientific Consultant, Spotfire, Inc.,
       to present, "Integrating Toxicogenomics into Pre-Clinical
       Development and How to Handle the Data Generated"

Where: Vision in Business 2001 Conference: Reducing In-Vivo Testing
       and Improving Predictability. Advances in Pre-Clinical
       Screening in Geneva, Switzerland

When:  March 14, 2001
       (Conference runs March 14 - 15, 2001)

Dr. Mark Demesmaeker is presenting at the Vision in Business 2001 Conference: "Reducing In-Vivo Testing and Improving Predictability. Advances in Pre-Clinical Screening," an international conference focused on the latest developments in technologies to improve pre-clinical development. He will provide an overview of the high-throughput techniques recently introduced to pre-clinical development screening, such as automated in-vitro absorption testing, in-vivo pre-clinical safety testing and in-silico modeling. As part of his overview of these techniques, he will demonstrate how Spotfire DecisionSite eAnalytic applications are being used by the leading pharmaceutical and biotechnology companies to extract the crucial information stored in disparate databases, enabling scientists to make faster, more informed decisions.

Dr. Demesmaeker joined Spotfire in January 2000 from the World Health Organization, Geneva, Switzerland, where he served as Associate Professional Officer in the department of Quality Assurance & Safety: Medicines.

About Spotfire(R)

Spotfire, Inc. is a leading provider of eAnalytic applications and services that put the power of decision-making at the center of its customers' businesses. Spotfire's solutions enable organizations around the world to improve the efficiency, the speed and the accuracy of their decision-making processes by advancing both individual and networked analysis. The company maintains U.S. headquarters in Cambridge, Mass. and European headquarters in Goteborg, Sweden. Additional information can be found at http://www.spotfire.com.

Spotfire is a registered trademark and DecisionSite is a trademark of Spotfire, Inc. All other names or marks may be registered trademarks or trademarks of their respective owners and are hereby acknowledged.